Clever Leaves (CLVR) Competitors $0.0003 0.00 (0.00%) As of 08/22/2025 03:47 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock CLVR vs. AMPE, PXMD, CALA, EFTR, HSTO, ONCSQ, ATNFW, LBPSW, AEHAW, and AIMDWShould you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include Ampio Pharmaceuticals (AMPE), PaxMedica (PXMD), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), Histogen (HSTO), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), and Ainos (AIMDW). These companies are all part of the "pharmaceutical products" industry. Clever Leaves vs. Its Competitors Ampio Pharmaceuticals PaxMedica Calithera Biosciences eFFECTOR Therapeutics Histogen OncoSec Medical 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Clever Leaves (NASDAQ:CLVR) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability. Does the media prefer CLVR or AMPE? In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score. Company Overall Sentiment Clever Leaves Neutral Ampio Pharmaceuticals Neutral Which has more risk & volatility, CLVR or AMPE? Clever Leaves has a beta of 3531.01, indicating that its stock price is 353,001% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 4.69, indicating that its stock price is 369% more volatile than the S&P 500. Which has better earnings & valuation, CLVR or AMPE? Ampio Pharmaceuticals has lower revenue, but higher earnings than Clever Leaves. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClever Leaves$17.42M0.00-$17.90M-$11.310.00Ampio PharmaceuticalsN/AN/A-$8.63M-$11.010.00 Is CLVR or AMPE more profitable? Company Net Margins Return on Equity Return on Assets Clever LeavesN/A N/A N/A Ampio Pharmaceuticals N/A N/A N/A Do insiders & institutionals believe in CLVR or AMPE? 6.9% of Clever Leaves shares are owned by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryClever Leaves beats Ampio Pharmaceuticals on 5 of the 7 factors compared between the two stocks. Get Clever Leaves News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart CLVR vs. The Competition Export to ExcelMetricClever LeavesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$833.52M$5.81B$9.76BDividend YieldN/A4.84%4.39%4.06%P/E Ratio0.001.1831.3626.05Price / Sales0.00152.90387.8788.42Price / CashN/A19.5638.0259.36Price / Book0.006.649.536.60Net Income-$17.90M-$4.94M$3.26B$265.65M7 Day PerformanceN/A1.85%2.14%2.00%1 Month PerformanceN/A3.06%3.22%0.46%1 Year PerformanceN/A12.25%30.18%18.88% Clever Leaves Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVRClever LeavesN/A$0.00flatN/A-99.0%$1K$17.42M0.00560AMPEAmpio PharmaceuticalsN/A$0.00flatN/A+3.8%$3KN/A0.0020PXMDPaxMedicaN/A$0.00flatN/AN/A$2KN/A0.002CALACalithera Biosciences0.6159 of 5 stars$0.00-80.0%N/A-98.4%$1KN/A0.0060Gap DownEFTReFFECTOR TherapeuticsN/A$0.00flatN/A-99.6%$1KN/A0.0010High Trading VolumeHSTOHistogenN/A$0.00flatN/A-99.9%$1K$19K0.0020ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040ATNFW180 Life SciencesN/A$0.38-11.6%N/A+2,400.6%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002AIMDWAinosN/A$0.51+2.2%N/AN/A$0.00$106.21K0.0040Gap Up Related Companies and Tools Related Companies AMPE Alternatives PXMD Alternatives CALA Alternatives EFTR Alternatives HSTO Alternatives ONCSQ Alternatives ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLVR) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clever Leaves With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access